The goals of our industry collaborations are to:
As part of this initiative, S&PAA has provided significant patient insights on clinical trial design, patient preferences and expectations and other topics related to the development of new treatments.
SPAN is focused on policy advocacy and action opportunities. S&PAA provides broader resources across research, education, care and advocacy for people affected by schizophrenia and psychosis disorders.